Study on Failed Back Surgery Syndrome Pathway Optimization: A Focus on Patient Identification, Chronicization Factors and Outcome Predictors (PREDIBACK)

July 3, 2019 updated by: Poitiers University Hospital

A Multicenter Prospective Study on Failed Back Surgery Syndrome Pathway Optimization: A Focus on Patient Identification, Chronicization Factors and Outcome Predictors

This pilot study is part of a global project that aims to better define and understand features of FBSS/POPS "post-operative persistent syndrome patients (shortened as "FBSS" in the following project). FBSS is the acronym for Failed Back Surgery Syndrome, which has been defined as a chronic condition resulting from spinal interventions. Despite anatomically successful spine surgery, a significant proportion of patients is experiencing chronic refractory back and leg pain. In a recent multicentre study conducted on more than 100 refractory FBSS patients, (ESTIMET Study), the mean delay between pain occurrence and FBSS diagnosis was 5 years. Therefore, FBSS pattern and potential responder stratification might guide us to eventually develop a decision tool for identifying FBSS patients. Easing and helping diagnosis of FBSS should improve referral yield to specialists and accelerate patient flow through the care pathway. Hence, FBSS patients, who usually present a long standing history of pain, would have access to "appropriate" therapies earlier. This could lead to better outcomes. The aim of this multicentre, prospective study is to collect specific data that are not collected in routine in order to better define and understand the potential FBSS population and to accelerate the diagnostic and optimize the choice of appropriate treatment.

A multidisciplinary approach through a pain management clinical network, as it has been structured in Poitiers, will ensure that an exhaustive characterization of FBSS patients and their care pathway will be collected. In addition, since the cooperation between orthopaedic and neuro spine surgeons is not a common relationship found all over Europe (as it is observed in Poitiers), this study also aims to better understand the development of interactions between physicians/professionals and the substantial advantage which would result from bridging this gap. The N3MT (NeuroMapping Tools) software developed in Poitiers to collect data and assess objectively pain surface and intensity changes, before/after any treatment, with quantitative measurements, will be used as the central key of this project.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Poitiers, France
        • Poitiers Hospital University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient has signed and dated the Informed Consent Form.
  • Patient is ≥ 18 years of age at time of "Informed Consent Form" signature.
  • Patient had most recent back surgery more than 6 months ago.
  • Patient has developed post-operative Chronic Back with or without Leg Pain (potential FBSS).
  • Patient has persistent back pain for more than 6 months.
  • Average low back or leg pain is ≥ 4 as assessed by the baseline NPRS.

Exclusion Criteria:

  • Patient has already a confirmed FBSS diagnosis.
  • Patient is or has been treated with SCS, subcutaneous or peripheral nerve stimulation, an intrathecal drug delivery system.
  • Investigator suspects substance abuse that might confound the study results.
  • Patient has a life expectancy of less than 12 months beyond study enrollment.
  • Patient is less than 18 years of age.
  • Patient is pregnant or planning to become pregnant during the course of the study.
  • Patient is unable to undergo study assessments or complete questionnaires independently (e.g., is illiterate).
  • Patient is a member of a vulnerable population.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Follow-up patient
Medical follow-up visit

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of clinical diagnosis of FBSS
Time Frame: 12 month-follow up visit
Incidence of clinical diagnosis of FBSS in the broad population of post-surgical pain syndrome, identified by multidisciplinary team of independent experts (1 pain physician, 1 neurosurgeon and 1 psychiatric), with morphological and clinical characterization of the syndrome.
12 month-follow up visit

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity (NRPS)
Time Frame: Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
  • Reduction of the NRPS score measuring pain intensity: Global pain, Back pain and Leg pain.
  • Proportion of patients with NRPS score < 4.
  • Proportion of patients obtaining a reduction ≥ 25%, 50% and 75%: Global pain, Back pain and Leg pain NRPS.
Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Pain surface and intensity (Mapping Tool)
Time Frame: Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
  • Reduction of the Global Pain Surface measured on the NeuroPain't module of the software, during treatment, before/after a therapeutic strategy is used.
  • Reduction of pain intensities associated with the quantitative surface measurements.
  • Reduction of the mechanical/neuropathic component of objective pain.
Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Functional capacity (ODI)
Time Frame: Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Quality of life (EQ5D)
Time Frame: Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Psychological State (HADS)
Time Frame: Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Pain Catastrophizing Scale (PCS CF)
Time Frame: Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Adverse Events/ Serious Adverse Events
Time Frame: Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits
Initial visit and 3 month, 6 month, 9 month and 12 month-follow up Visits

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Philippe RIGOARD, PU-PH, Poitiers Hospital University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

May 16, 2019

Study Completion (Actual)

May 31, 2019

Study Registration Dates

First Submitted

November 7, 2016

First Submitted That Met QC Criteria

November 14, 2016

First Posted (Estimate)

November 15, 2016

Study Record Updates

Last Update Posted (Actual)

July 5, 2019

Last Update Submitted That Met QC Criteria

July 3, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Pain

Clinical Trials on No name

3
Subscribe